BN Business News
Add your company to Business Communicator →

Business · 12/01/1999

FDA Approves Clomipramine Hydrochloride Tablets for Separation Anxiety in Dogs

The FDA is amending its regulations to allow the use of Novartis Animal Health US, Inc.'s clomipramine hydrochloride tablets as part of a behavioral management program to treat separation anxiety in dogs over 6 months old.

Original source language: Federal Register — Food and Drug AdministrationOpen original release →

Explore insights